ResMed Inc., a leading player in the sleep and respiratory care industry, is headquartered in the United States, with significant operations across Europe, Asia, and Australia. Founded in 1989, ResMed has consistently innovated in the development of cloud-connected devices and software solutions that enhance patient care and improve quality of life for those with sleep apnoea and chronic obstructive pulmonary disease (COPD).
The company’s core offerings include advanced continuous positive airway pressure (CPAP) devices, portable oxygen concentrators, and digital health solutions, all designed to provide seamless integration and user-friendly experiences. ResMed's commitment to research and development has positioned it as a market leader, recognised for its pioneering technologies and significant contributions to the field of sleep medicine. With a strong focus on improving patient outcomes, ResMed continues to set benchmarks in the healthcare industry.
+14 vs industry average
Resmed’s score of 41 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Resmed?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Resmed's reported carbon emissions
In 2024, ResMed, headquartered in the United States, reported total greenhouse gas emissions of approximately 42,360,000 kg CO2e, comprising 4,236,000 kg CO2e from Scope 1 and 24,422,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. This target reflects a significant commitment to sustainability within the healthcare equipment sector. ResMed's emissions data shows a slight decrease from 2023, where total emissions were approximately 44,530,000 kg CO2e, with Scope 1 at 4,453,000 kg CO2e and Scope 2 at 23,939,000 kg CO2e. The company has also reported a reduction of 13.8% in greenhouse gas emissions from 2018 to 2019, indicating a proactive approach to managing its carbon footprint. In addition to its near-term targets, ResMed has committed to achieving net-zero emissions across all scopes by 2050, with interim targets of reducing absolute Scope 1 and 2 emissions by 42% by 2030 from a 2022 baseline. This long-term strategy aligns with industry standards for climate action and reflects ResMed's dedication to environmental responsibility. Overall, ResMed's emissions reduction initiatives and commitments position it as a leader in the healthcare sector's transition towards sustainability.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Resmed’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Resmed yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Resmed
Frequently asked questions
Common questions about Resmed’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project